Healix Executive and Leadership Team

Brit Pim, the Chief Executive Officer at Healix, directs the overarching corporate strategy for physician office-based infusion services. Pim manages the executive team to ensure alignment with long-term growth objectives and clinical excellence standards. By overseeing national market expansion, the Chief Executive Officer drives the adoption of outpatient infusion models that enhance patient access to specialized therapies. Pim collaborates with the Board to refine service delivery frameworks, ensuring that every office-based infusion site maintains rigorous compliance and safety protocols. This leadership role involves constant evaluation of healthcare trends to maintain the company's position as a market leader. Through the optimization of internal resources and the cultivation of strategic partnerships, Brit Pim secures the operational stability necessary for sustained success. The Chief Executive Officer remains focused on delivering peace of mind to both physicians and patients through high-quality, accessible care solutions.

Becky White-Steensma, the Chief Executive Officer & Founder at Healix, architects the foundational vision for physician-led infusion care. White-Steensma drives the mission of providing unparalleled clinical outcomes within outpatient settings, focusing on the integration of specialized services into existing medical practices. The Chief Executive Officer & Founder oversees the long-term evolution of the company's service model, ensuring that innovation remains at the core of every patient interaction. By guiding the strategic direction of the organization, White-Steensma fosters a culture of excellence that supports physician autonomy and patient comfort. This leadership role involves high-level engagement with industry stakeholders to advocate for the benefits of office-based infusion. Through the consistent application of clinical standards, Becky White-Steensma ensures that the company continues to set the benchmark for quality in the infusion services sector, ultimately strengthening the national footprint of the organization.

Melisa Norton, the Chief Financial Officer at Healix, manages the fiscal health and capital allocation strategies for the organization. Norton oversees all financial reporting, budgeting, and revenue cycle management processes to ensure the sustainability of office-based infusion operations. The Chief Financial Officer drives cost-efficiency initiatives that allow the company to scale its services across diverse medical practices nationwide. By analyzing market data and financial performance metrics, Norton provides the insights necessary for the executive team to make informed investment decisions. This leadership role involves maintaining robust internal controls and ensuring compliance with healthcare financial regulations. Through the strategic management of assets and liabilities, Melisa Norton supports the company's mission of providing high-quality patient care while maintaining strong profitability. The Chief Financial Officer works closely with other leaders to align financial goals with the broader operational objectives of the firm.

Casey Lucas, the Chief Operating Officer & Executive VP, Sales at Healix, directs the daily operational workflows and national sales initiatives for the company. Lucas oversees the implementation of infusion service programs within physician offices, ensuring that each site meets strict clinical and operational standards. The Chief Operating Officer & Executive VP, Sales drives the expansion of the company's client base by identifying new opportunities for physician partnerships across various regions. By managing the sales force and operational support teams, Lucas ensures that service delivery remains consistent and efficient. This leadership role involves coordinating with clinical staff to optimize patient care pathways and improve overall service quality. Through the execution of strategic sales plans, Casey Lucas directly impacts the growth and market penetration of the organization. The Chief Operating Officer & Executive VP, Sales maintains a focus on operational excellence to support the company's commitment to patient and physician peace of mind.

Mark Winters, the Partner, Executive Board Member, President at Healix, governs the strategic direction and high-level decision-making processes of the organization. Winters oversees the alignment of corporate governance with the company's mission of providing superior outpatient infusion services. As a key member of the executive board, the Partner, Executive Board Member, President drives initiatives that strengthen the company's market position and long-term viability. By fostering relationships with key stakeholders and industry partners, Winters ensures that the organization remains at the forefront of clinical innovation. This leadership role involves evaluating large-scale business opportunities and guiding the company through complex market shifts. Through the application of deep industry expertise, Mark Winters supports the development of sustainable business practices that benefit both physicians and patients. The Partner, Executive Board Member, President remains dedicated to upholding the company's reputation for excellence and clinical integrity.

Tom Reinckens, the Chief Information & Procurement Officer at Healix, directs the technological infrastructure and supply chain management for the company. Reinckens oversees the procurement of essential infusion medications and supplies, ensuring that every physician office has the resources required for optimal patient care. The Chief Information & Procurement Officer drives the implementation of digital systems that enhance clinical compliance and operational efficiency. By managing vendor relationships and negotiating supply contracts, Reinckens secures the cost-effective delivery of high-quality medical products. This leadership role involves protecting sensitive patient data through robust cybersecurity measures and maintaining the integrity of the company's information systems. Through the integration of advanced procurement and IT strategies, Tom Reinckens supports the seamless operation of infusion services across the nation. The Chief Information & Procurement Officer ensures that technology and supply chain logistics remain aligned with the company's commitment to clinical excellence.

Blake Griese, the General Counsel & Head of Pharmacy at Healix, manages the legal framework and pharmaceutical operations for the organization. Griese oversees regulatory compliance, contract negotiations, and the legal aspects of physician partnerships to ensure the company operates within all healthcare guidelines. As the Head of Pharmacy, the General Counsel & Head of Pharmacy drives the development of pharmacy protocols that prioritize patient safety and clinical outcomes. By monitoring changes in healthcare law and pharmacy regulations, Griese ensures that the company remains proactive in its compliance efforts. This leadership role involves providing legal guidance to the executive team and overseeing the pharmacy staff to maintain high standards of care. Through the integration of legal and pharmaceutical expertise, Blake Griese supports the company's mission of providing reliable infusion services. The General Counsel & Head of Pharmacy remains focused on mitigating risk while fostering an environment of clinical quality.